NIH-funded research NIH-funded research

Creating a test to detect HIV and Hepatitis B in low-income countries

Official title: Development of a Multiplex Quantitative PCR Assay for HIV and Hepatitis B Virus, for Low- and middle Income Countries

Funded at Univ of Sciences, Tech & Tech of Bamako · NIH-11093357 · Data updated 2026-11-12

This study is testing a new blood test that can quickly find both HIV and Hepatitis B infections, especially for people in places like Mali, so doctors can provide better treatment for those at risk.

More Hepatitis B research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of Sciences, Tech & Tech of Bamako
NIH-funded
Lab location1 site (Bamako, Mali)
Project startAugust 23, 2021
Project endMay 31, 2026
Funding year2025
Award (this year)$100,440
NIH project number5K43TW011957-05
Project IDNIH-11093357 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals living in Mali who are at risk for HIV and Hepatitis B, particularly those in high-prevalence groups such as pregnant women and blood donors.

Less likely to help

Patients who are not at risk for HIV or Hepatitis B, or those living outside of the targeted geographic area, may not benefit from this research.

What this research studies

This research focuses on developing a multiplex quantitative PCR assay to detect both HIV and Hepatitis B virus (HBV) infections, particularly in low- and middle-income countries like Mali. The approach aims to improve early detection of HBV, which often goes unnoticed due to its asymptomatic nature, especially in individuals already at risk for HIV. By accurately identifying these infections, healthcare providers can better tailor antiretroviral therapy regimens to improve patient outcomes. The study will involve collecting and analyzing blood samples to validate the effectiveness of the new testing method.

Why it matters

Potential benefit: If successful, this research could lead to improved early detection and treatment of HIV and Hepatitis B, ultimately reducing complications and mortality rates in affected populations.

How similar studies have gone: Previous research has shown success in developing similar assays for viral detection, indicating a promising potential for this approach in low-resource settings.

Where this research is happening

  • Univ of Sciences, Tech & Tech of Bamako
    Bamako, Mali
    Active

Researchers

  • Principal investigator: Fofana, Djeneba Bocar — Univ of Sciences, Tech & Tech of Bamako
  • Study coordinator: Fofana, Djeneba Bocar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.